Klivira
Request demo

Optimizing Infectious Disease OptumRx Integration for Prior Authorization

Klivira's infectious disease OptumRx integration automates the complex prior authorization process for high-cost antimicrobial therapies and specialty drugs, ensuring rapid approval for critical patient care.

Revenue cycle directors and prior authorization coordinators in infectious disease practices face unique challenges with PBM authorizations. The high cost and strict medical necessity criteria for antivirals, antifungals, and OPAT regimens often lead to delays and administrative burden. Klivira addresses these challenges by automating the data exchange and submission workflow with OptumRx.

Streamlining High-Cost Antimicrobial Prior Authorizations with OptumRx

Infectious disease prior authorizations frequently involve high-cost, specialty pharmaceuticals crucial for patient outcomes, such as direct-acting antivirals for Hepatitis C, complex HIV regimens, and advanced antifungals. OptumRx, as a major PBM, requires precise clinical documentation to approve these therapies. Klivira's platform automates the synthesis and submission of this data, minimizing manual effort and accelerating approval times.

Key Prior Authorization Triggers for ID Prescriptions with OptumRx

  • High-cost antivirals (e.g., HCV direct-acting antivirals, novel HIV integrase inhibitors or combination therapies)
  • Specific antifungals (e.g., echinocandins, voriconazole, isavuconazole)
  • Outpatient Parenteral Antibiotic Therapy (OPAT) regimens and associated services
  • Immunomodulators or biologics used in specific infectious disease contexts
  • Novel antibiotics for multi-drug resistant organisms

EMR-to-OptumRx Data Exchange for Infectious Disease Workflows

Effective prior authorization relies on seamless data flow from the EMR to the payer. For infectious disease cases, Klivira extracts critical clinical data points from your EMR (e.g., Epic, Cerner, Meditech) via secure interfaces like SMART on FHIR. This includes lab results (viral loads, resistance testing, liver/renal function), physician notes detailing diagnosis and treatment rationale, and medication history, which are then formatted for submission to OptumRx via X12 278 or direct ePA channels.

Essential Clinical Documentation for OptumRx ID PAs

  • Pathogen identification and susceptibility testing results
  • Viral load counts (e.g., HIV, HCV) and genotypic resistance profiles
  • Documentation of prior treatment failures or contraindications to preferred agents
  • Infectious Disease specialist consultation notes and treatment plans
  • Evidence of disease progression or severity (e.g., CD4 counts, liver fibrosis scores)
  • Relevant imaging reports (e.g., CT, MRI for osteomyelitis or abscesses)

Aligning with Clinical Guidelines for OptumRx Approvals

Prior authorization denials often stem from a lack of alignment with established clinical guidelines. Klivira's platform helps ensure that submissions for infectious disease therapies are evidence-based, referencing bodies like the Infectious Diseases Society of America (IDSA), American Association for the Study of Liver Diseases (AASLD), and HIV Medicine Association (HIVMA). This structured approach supports medical necessity arguments required by OptumRx, improving approval rates and reducing appeals.

Optimizing OPAT and Specialty Pharmacy Authorizations

The coordination required for Outpatient Parenteral Antibiotic Therapy (OPAT) and other specialty pharmacy services presents a significant PA challenge. Klivira's integration with OptumRx streamlines the authorization for these complex regimens, encompassing not just the drug but also associated administration and monitoring. This ensures that patients receive timely access to home-based care or specialty pharmacy dispensed medications, critical for managing chronic or severe infections.

Frequently asked questions

How does Klivira handle specific lab values required by OptumRx for HIV or HCV drugs?

Klivira's EMR integration automatically identifies and extracts relevant lab values, such as viral loads, CD4 counts, or HCV genotypes, from your patient records. These data points are then mapped and included in the X12 278 submission or ePA portal entry for OptumRx, ensuring all necessary clinical criteria are met without manual data entry.

Can Klivira integrate with our EMR to pull ID progress notes for OptumRx submissions?

Yes, Klivira is designed to integrate with leading EMR systems to pull comprehensive clinical documentation, including infectious disease progress notes, consultation reports, and treatment plans. This ensures that the qualitative clinical rationale required by OptumRx for complex ID cases is seamlessly included in the prior authorization submission.

Does Klivira support both standard and specialty pharmacy OptumRx PAs for infectious disease?

Absolutely. Klivira's platform is built to handle the full spectrum of OptumRx prior authorizations, covering both standard pharmacy medications and the often more complex specialty pharmacy drugs essential for infectious disease management. This includes high-cost antivirals, antifungals, and other critical therapies.

How does Klivira manage re-authorizations for chronic ID conditions like HIV?

For chronic infectious diseases requiring ongoing therapy, Klivira tracks authorization expiration dates and proactively initiates re-authorization workflows. The system leverages previously submitted data and updates with current clinical information from the EMR to facilitate timely re-submissions to OptumRx, minimizing gaps in patient care.

What is the typical impact on denial rates for ID PAs with OptumRx using Klivira?

While we cannot guarantee specific denial rate reductions, Klivira's automated data extraction and structured submission process significantly improve the completeness and accuracy of prior authorization requests. By ensuring all required clinical documentation and medical necessity criteria are met upfront, our clients typically experience a notable reduction in denials and appeals for OptumRx ID PAs.

Related coverage

Other infectious-disease prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo